Planet Labs PBC PL
17.43
(0.19)
(1.08%)
as of 25 Sep
- Market cap
- $6.6B
- P/E
- 0.0×
Follow PL
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
14.73 | 22.86 | 38.06 | 19.47 | |
P/FCF ratio |
115.14 | 133.04 | 301.66 | 370.60 | |
P/Operating CF |
145.47 | 340.61 | 827.33 | 139.09 | |
P/B ratio |
11.90 | 37.33 | 28.79 | 13.05 | |
Price to Tangible BV |
22.48 | 383.36 | 46.38 | 18.73 | |
EV/Sales |
13.93 | 22.25 | 37.24 | 18.38 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
36.64 | 50.96 | 94.36 | 59.11 | |
EV/FCF |
108.94 | 129.53 | 295.14 | 349.92 | |
Quick Ratio |
3.84 | 1.54 | 2.62 | 2.64 | |
Current Ratio |
4.00 | 1.65 | 2.81 | 2.84 | |
Net Debt/EBITDA |
27.52 | 7.52 | 11.99 | 154.01 | |
Debt/Assets |
40.34% | 39.01% | 35.76% | 31.33% | |
Debt/Equity |
1.28 | 2.37 | 1.01 | 0.79 | |
Asset Turnover |
0.33 | 0.35 | 0.35 | 0.36 | |
Operating CF/Net income |
(0.48) | (0.14) | (0.11) | (5.66) | |
Capex/Depreciation |
(2.79) | (2.25) | (1.60) | (2.70) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
33.63% | 37.08% | 35.50% | 30.29% | |
Selling, General and Administrative Expense of Revenue |
46.27% | 58.56% | 55.09% | 37.90% | |
Intangible Assets out of Total Assets |
0.15 | 0.15 | 0.13 | 0.12 | |
Share Based Compensation of Revenue |
16.58% | 17.88% | 17.48% | 14.70% | |
Graham Net Nets |
0.00 | (0.03) | 0.00 | 0.02 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(3.12%) | (3.41%) | (3.08%) | (5.37%) | |
Free Cash Flow Yield |
0.87% | 0.75% | 0.33% | 0.27% | |
Revenue per Share |
0.26 | 0.28 | 0.27 | 0.32 | |
Operating CF per Share |
0.09 | 0.07 | 0.04 | 0.15 | |
Capex per Share |
(0.09) | (0.07) | (0.05) | (0.08) | |
Free Cash Flow per Share |
0.00 | (0.01) | (0.01) | 0.07 | |
Cash per Share |
2.19 | 2.08 | 2.12 | 2.41 | |
Shareholders Equity per Share |
1.13 | 0.61 | 1.28 | 1.57 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.13 | 0.61 | 1.28 | 1.57 | |
Free Cash Flow |
0.91 | (2.34) | (2.52) | 23.81 | |
Working Capital |
565.55 | 305.91 | 546.43 | 647.52 | |
Capital Expenditures |
(27.68) | (22.98) | (17.96) | (29.13) | |
Net Current Asset Value |
(2.36) | (181.89) | 41.25 | 132.18 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.34 | 0.26 | 0.19 | 0.25 | |
Net Profit Margin |
(72.84%) | (175.59%) | (147.50%) | (8.06%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
42.59 | 69.68 | 68.13 | 55.75 | |
Average Payables |
3.51 | 6.61 | 6.57 | 10.70 | |
Average Assets |
868.41 | 889.74 | 954.91 | 1,063.69 | |
Average Common Equity |
407.08 | 314.86 | 444.25 | 500.02 |
Columns are period end dates